| Literature DB >> 29663538 |
Li-Chia Tai1,2,3, Wei Gao1,2,3, Minghan Chao1,2,3, Mallika Bariya1,2,3, Quynh P Ngo1,2,3, Ziba Shahpar1,2,3, Hnin Y Y Nyein1,2,3, Hyejin Park4, Junfeng Sun4, Younsu Jung4, Eric Wu1,2,3, Hossain M Fahad1,2,3, Der-Hsien Lien1,2,3, Hiroki Ota1,2,3, Gyoujin Cho4, Ali Javey1,2,3.
Abstract
Drug monitoring plays crucial roles in doping control and precision medicine. It helps physicians tailor drug dosage for optimal benefits, track patients' compliance to prescriptions, and understand the complex pharmacokinetics of drugs. Conventional drug tests rely on invasive blood draws. While urine and sweat are attractive alternative biofluids, the state-of-the-art methods require separate sample collection and processing steps and fail to provide real-time information. Here, a wearable platform equipped with an electrochemical differential pulse voltammetry sensing module for drug monitoring is presented. A methylxanthine drug, caffeine, is selected to demonstrate the platform's functionalities. Sweat caffeine levels are monitored under various conditions, such as drug doses and measurement time after drug intake. Elevated sweat caffeine levels upon increasing dosage and confirmable caffeine physiological trends are observed. This work leverages a wearable sweat sensing platform toward noninvasive and continuous point-of-care drug monitoring and management.Entities:
Keywords: drug monitoring; electrochemical sensors; flexible electronics; wearable biosensors
Mesh:
Substances:
Year: 2018 PMID: 29663538 DOI: 10.1002/adma.201707442
Source DB: PubMed Journal: Adv Mater ISSN: 0935-9648 Impact factor: 30.849